Key takeaway: The investor presentation from Ion Exchange (India) Limited, dated August 10, 2026, outlines the company's extensive experience of over 62 years and operations in more than 50 countries. It highlights their commitment to total water and environment management, showcasing a diverse portfolio that includes ultrapure water, wastewater treatment, and zero liquid discharge solutions. The presentation details the company's global manufacturing facilities and advanced R&D centers, emphasizing their leadership in sustainability and innovation. Key attributes include over 200,000 installations worldwide and a significant international revenue share. The document also discusses strategic investments aimed at capacity expansion and technology leadership, particularly in industrial and pharmaceutical resins. Financial data indicates revenue growth across various segments, with a focus on enhancing operational capabilities and customer service.

Key takeaway: The investor presentation submitted by Ion Exchange (India) Limited on August 10, 2026, outlines the company's extensive experience in water and environment management, highlighting over 62 years of expertise and operations in more than 50 countries. The presentation details the company's commitment to sustainability and its comprehensive portfolio, which includes solutions for water treatment, wastewater management, and specialty chemicals. Ion Exchange reported having over 200,000 installations worldwide and a significant presence in various industries, including infrastructure, pharmaceuticals, and food and beverages. The document also emphasizes the company's strategic investments in technology and capacity expansion, aiming to enhance its manufacturing capabilities and market share. Additionally, it showcases the company's global manufacturing facilities and R&D centers, reinforcing its position as a leader in the water treatment sector.

Key takeaway: On May 29, 2026, Ion Exchange (India) Limited held its earnings conference call for Q4 FY 2025-26, where management reported a consolidated operating income of INR 8,633 million, a 3% year-on-year increase. EBITDA was INR 199 million with a margin of 2.31%, while net profit reached INR 243 million, resulting in a PAT margin of 2.81%. For the full financial year, operating income rose 7% to INR 29,148 million, but EBITDA fell 29% to INR 2,102 million. The engineering segment reported flat revenue at INR 5,539 million, impacted by disruptions from the West Asia crisis. The chemical segment saw a 3% revenue increase to INR 2,297 million, while the consumer products division grew 34% year-on-year. Management highlighted strategic partnerships, including a collaboration with MANN+HUMMEL to enhance membrane technology, and discussed ongoing projects in Oman and Malawi. The call concluded with a Q&A session addressing various operational queries.

Key takeaway: On February 2, 2026, Ion Exchange (India) Limited held its earnings conference call to discuss its operational and financial performance for Q3 FY 2025-26. Management reported a consolidated operating income of INR 7,344 million, a 6% year-on-year increase, while EBITDA declined by 21% to INR 593 million. The net profit for the quarter was INR 206 million, with a PAT margin of 2.81%. For the nine months ended December 31, 2025, operating income rose by 8% to INR 20,516 million, but EBITDA fell by 9%. Management highlighted challenges in the Engineering division due to project delays and funding issues, while the Chemical division faced profitability pressures from product mix and costs. The Consumer Product division saw a revenue increase of 28% year-on-year, although it reported a loss. Management discussed the implications of the recent Union Budget, noting increased government support for infrastructure and sustainability projects, which could benefit the company in the long term.